From: “VERACARE” To: “Dr. Bart Campbell” Subject: RE: AHRP Response to criticism re: fatal ARDS lung experiment Date: Tue, 1 Jul 2003 ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) https://ahrp.org//testimonypresentations/ARDSNet0603/sharav.html
Next Phase in Psychiatry? Or, NIMH Effort to Rescue Bad Drugs – WSJ Fri, 29 Jul 2005 The Wall Street Journal uncritically reported: “The results of the largest studies ever conducted of depression and schizophrenia will be released in coming months, potentially transforming the way patients are treated and shaking…
Antidepressants Pregnancy Risk: Babies Adversely Affected Sat, 5 Feb 2005 Thanks to the BBC 3-part Panorama series (beginning October 2002), it is no longer a secret that coming off SSRI antidepressants can cause serious symptoms of withdrawal in some users. Christopher Pittman is on trial for killing his grandparents while…
Integrity of Medical Regulators Wed, 8 Jun 2005 The UK MHRA (equivalent of US FDA) has been caught in flat out public deception. The MHRA–which is entirely funded by the pharmaceutical industry–had claimed that two thirds of professional organizations it consulted favored selling a heart medication (Zocor Heart-Pro) without a…
Lilly Consultants dismiss significance of suicide risk while Lilly will issue Black Box warning label for Strattera Mon, 10 Oct 2005 On September 29, the FDA issued the public health advisory alerting health care professionals that children and adolescents taking Strattera prescribed for ADHD should be closely monitored for changes…
Pfizer Must Hand Over Documents in Pitman Case Sat, 4 Dec 2004 A federal judge in Charlotte North Carolina rejected Pfizer’s arguments and ordered the company to hand over the concealed documents sought by defense counsels in the criminal case against Christopher Pitman, a teenager who, at the age of…
July 14, 2002 Corporate Influence on Medicine, Healthcare Budgets, Investors FYI Because medicine’s pronouncements are so widely propagated and affect so many people’s lives, corporate influence and manipulation of the truth is more devastating than mere corporate accounting malfeasance. Recent revelations demonstrate how corporate influence and greed – rather than…
Bayer/ Baycol on Trial in Texas_NYT Sat, 1 Mar 2003 Melody Peterson of the New York Times reports that in the first case brought against Bayer involving its anticholesterol drug, Baycol, a senior official of Bayer AG testified in court in Corpus Cristi, Texas. He acknowledged that company officials in…
A Special Article By Curt D. Furberg, MD, PhD; Arthur A. Levin, MPH; Peter A. Gross, MD; Robyn S. Shapiro, JD; Brian L. Strom, MD, MPH
The battle lines were drawn between those who recognize the corrosive effect that the pharmaceutical industry is having on the safety and integrity of medicine and medical research, and the powerful stakeholders–the pharmaceutical-academic industrial complex.
Dr. Sanghavi provides us with a statistical reality-check by which to gauge for ourselves whether or not we should–or need not–take a octor’s advice about starting a medical treatment for a speculated risk–rather than evidence of illness.
A report by the Institute of Medicine is sharply critical of FDA’s drug safety monitoring system: "The report’s conclusions are striking and often damning – particularly when discussing the agency’s Center for Drug Evaluation and Research, known as C.D.E.R."
